Novosteo
West Lafayette, US · Founded 2017 · Delaware corporation · 16 employees on LinkedIn · 3 known investors
Quince Therapeutics is a clinical-stage biopharmaceutical company developing eDSP, an investigational therapy studied in a Phase 3 clinical trial (NEAT) for patients with Ataxia-Telangiectasia (A-T). The company focuses on treatments for rare and debilitating diseases.
Founders & leadership
Novosteo was founded in 2017 by Philip S. Low, Ph.D..
PS
Philip S. Low, Ph.D.Founder
DL
David LamondNamed on SEC filing
DH
Daniel HaslerNamed on SEC filing
DT
Dirk Thye, M.D.Named on SEC filing
WJ
William J. RutterNamed on SEC filing
AA
Alex AndrianopoulosNamed on SEC filing
Investors · 3
Reported raises · per SEC filings
Form D private placements$17.7M disclosed across 1 round · 2020
▶$17.7MraisedApr 2022 · 37 investors · PharmaceuticalsRule 506(b)
▶$17.7MraisedApr 2022 · 37 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David LamondDirector
- Daniel HaslerDirector
- Dirk Thye, M.D.Executive Officer, Director
- William J. RutterDirector
- Alex AndrianopoulosDirector
- Philip S. Low, Ph.D.Executive Officer, Director
- Offering amount
- $17.7M
- Amount sold
- $17.7M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapQuince27 shared keywordsQuince is a direct-to-consumer clothing and home goods brand that sells sustainably manufactured essentials at affordable prices by eliminating supply chain intermediaries. The company sources premium materials like organic cotton and recycled polyester from ethical factories and sells directly to consumers, emphasizing quality, sustainability, and fair labor practices.
StockTwits20 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Companies competing with Novosteo for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Novosteo do?
- Quince Therapeutics is a clinical-stage biopharmaceutical company developing eDSP, an investigational therapy studied in a Phase 3 clinical trial (NEAT) for patients with Ataxia-Telangiectasia (A-T). The company focuses on treatments for rare and debilitating diseases.
- Who founded Novosteo?
- Novosteo was founded by Philip S. Low, Ph.D. in 2017.
- Who are Novosteo's investors?
- Novosteo's investors include Breakout Ventures, Elevate Ventures, Pfizer Venture Investments.
- How much funding has Novosteo raised?
- Novosteo has disclosed $17.7M raised across 1 round.
- Where is Novosteo headquartered?
- Novosteo is headquartered in West Lafayette, US.